Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value
$122.94+0.23 (+0.19%)
Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –
Haemonetics total assets
Total assets on the balance sheet at the end of each period.
Haemonetics's total assets was $2.41B at Sep 26, 2026. For fiscal 2026 it was $2.40B, down 2.2% from the year before. Over ten years it grew 6.1% a year on average. The highest annual figure on record is $2.45B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $2.40B | -2.2% |
| FY2025 | Mar 29, 2025 | $2.45B | +11.6% |
| FY2024 | Mar 30, 2024 | $2.20B | +13.5% |
| FY2023 | Apr 1, 2023 | $1.93B | +4.0% |
| FY2022 | Apr 2, 2022 | $1.86B | +2.2% |
| FY2021 | Apr 3, 2021 | $1.82B | +43.6% |
| FY2020 | Mar 28, 2020 | $1.27B | -0.6% |
| FY2019 | Mar 30, 2019 | $1.27B | +3.0% |
| FY2018 | Mar 31, 2018 | $1.24B | -0.1% |
| FY2017 | Apr 1, 2017 | $1.24B | -6.1% |
| FY2016 | Apr 2, 2016 | $1.32B | -11.2% |
| FY2015 | Mar 28, 2015 | $1.49B | -1.9% |
| FY2014 | Mar 29, 2014 | $1.51B | +3.6% |
| FY2013 | Mar 30, 2013 | $1.46B | +60.5% |
| FY2012 | Mar 31, 2012 | $911.14M | +9.3% |
| FY2011 | Apr 2, 2011 | $833.26M | +9.0% |
| FY2010 | Apr 3, 2010 | $764.31M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 26, 2026 | $2.41B | -1.3% |
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $2.37B | -3.9% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | $2.40B | -2.2% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $2.49B | -1.6% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $2.44B | -3.3% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $2.46B | -3.1% |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $2.45B | +11.6% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $2.53B | +15.0% |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $2.53B | +25.6% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | $2.54B | +29.5% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $2.20B | +13.5% |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | $2.20B | +17.2% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $2.01B | +7.8% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $1.96B | +7.8% |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | $1.93B | +4.0% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $1.88B | +2.5% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $1.87B | +3.5% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | $1.82B | +1.5% |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $1.86B | +2.2% |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $1.83B | +38.9% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $1.80B | +27.0% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | $1.79B | +25.2% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | $1.82B | +43.6% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $1.32B | +6.5% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $1.42B | +19.1% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $1.43B | +13.8% |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $1.27B | -0.6% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $1.24B | +0.8% |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $1.19B | -5.9% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | $1.26B | +1.5% |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $1.27B | +3.0% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | $1.23B | -6.4% |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $1.27B | -0.4% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $1.24B | -0.8% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $1.24B | -0.1% |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | $1.31B | +0.4% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $1.27B | – |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $1.25B | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | $1.24B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $1.31B | – |
See a number that looks wrong?